Fredun Pharmaceuticals (BOM:539730) 3-Year EBITDA Growth Rate : 52.90% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Fredun Pharmaceuticals 3-Year EBITDA Growth Rate?

Fredun Pharmaceuticals's EBITDA per Share for the three months ended in Mar. 2024 was ₹23.99.

During the past 12 months, Fredun Pharmaceuticals's average EBITDA Per Share Growth Rate was 32.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 52.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 23.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Fredun Pharmaceuticals was 52.90% per year. The lowest was 0.90% per year. And the median was 31.70% per year.

Competitive Comparison of Fredun Pharmaceuticals's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Fredun Pharmaceuticals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fredun Pharmaceuticals's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fredun Pharmaceuticals's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Fredun Pharmaceuticals's 3-Year EBITDA Growth Rate falls into.

Fredun Pharmaceuticals 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Fredun Pharmaceuticals (BOM:539730) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Fredun Pharmaceuticals 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Fredun Pharmaceuticals's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Fredun Pharmaceuticals (BOM:539730) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Ganpatrao Kadam Marg, 11th Floor, Urmi Estate, Lower Parel (West), Mumbai, MH, IND, 400013

Website

http://www.fredungroup.com

Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.

Fredun Pharmaceuticals (BOM:539730) Headlines

No Headlines